{{Rsnum
|rsid=894734
|Chromosome=12
|position=53925943
|Orientation=plus
|GMAF=0.3691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 49.6 | 43.4
| HCB | 3.6 | 33.6 | 62.8
| JPT | 0.9 | 35.4 | 63.7
| YRI | 42.2 | 44.9 | 12.9
| ASW | 30.4 | 42.9 | 26.8
| CHB | 3.6 | 33.6 | 62.8
| CHD | 3.7 | 33.9 | 62.4
| GIH | 20.8 | 45.5 | 33.7
| LWK | 41.8 | 51.8 | 6.4
| MEX | 0.0 | 47.4 | 52.6
| MKK | 38.5 | 45.5 | 16.0
| TSI | 10.8 | 46.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=4E-6
  |OR=1.62
  |ORtxt=[1.279-2.05]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}